164 related articles for article (PubMed ID: 35458758)
21. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
[TBL] [Abstract][Full Text] [Related]
22. Antiviral Activities of Officinaloside C against Herpes Simplex Virus-1.
Xiao J; Cai M; Wang Y; Ding P
Molecules; 2022 May; 27(11):. PubMed ID: 35684303
[TBL] [Abstract][Full Text] [Related]
23. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
Criscuolo E; Castelli M; Diotti RA; Amato V; Burioni R; Clementi M; Ambrosi A; Mancini N; Clementi N
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867302
[TBL] [Abstract][Full Text] [Related]
24. Samarangenin B from Limonium sinense suppresses herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis.
Kuo YC; Lin LC; Tsai WJ; Chou CJ; Kung SH; Ho YH
Antimicrob Agents Chemother; 2002 Sep; 46(9):2854-64. PubMed ID: 12183238
[TBL] [Abstract][Full Text] [Related]
25. Formulation and Evaluation of a Mucoadhesive Thermoresponsive System Containing Brazilian Green Propolis for the Treatment of Lesions Caused by Herpes Simplex Type I.
Mazia RS; de Araújo Pereira RR; de Francisco LM; Natali MR; Dias Filho BP; Nakamura CV; Bruschi ML; Ueda-Nakamura T
J Pharm Sci; 2016 Jan; 105(1):113-21. PubMed ID: 26852846
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.
Aniagyei SE; Sims LB; Malik DA; Tyo KM; Curry KC; Kim W; Hodge DA; Duan J; Steinbach-Rankins JM
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():238-251. PubMed ID: 28024582
[TBL] [Abstract][Full Text] [Related]
27. Antiviral activity against Zika virus of a new formulation of curcumin in poly lactic-co-glycolic acid nanoparticles.
Pacho MN; Pugni EN; Díaz Sierra JB; Morell ML; Sepúlveda CS; Damonte EB; García CC; D'Accorso NB
J Pharm Pharmacol; 2021 Mar; 73(3):357-365. PubMed ID: 33793877
[TBL] [Abstract][Full Text] [Related]
28. Inhibition effect of silver nanoparticles on herpes simplex virus 2.
Hu RL; Li SR; Kong FJ; Hou RJ; Guan XL; Guo F
Genet Mol Res; 2014 Mar; 13(3):7022-8. PubMed ID: 24682984
[TBL] [Abstract][Full Text] [Related]
29. Role of Phosphatidylethanolamine Biosynthesis in Herpes Simplex Virus 1-Infected Cells in Progeny Virus Morphogenesis in the Cytoplasm and in Viral Pathogenicity
Arii J; Fukui A; Shimanaka Y; Kono N; Arai H; Maruzuru Y; Koyanagi N; Kato A; Mori Y; Kawaguchi Y
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999028
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
[TBL] [Abstract][Full Text] [Related]
31. The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis.
Du Q; Gu Z; Leneva I; Jiang H; Li R; Deng L; Yang Z
Int Immunopharmacol; 2019 Mar; 68():58-67. PubMed ID: 30612085
[TBL] [Abstract][Full Text] [Related]
32. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.
Bhutta MS; Shechter O; Gallo ES; Martin SD; Jones E; Doncel GF; Borenstein R
Viruses; 2021 Jan; 13(1):. PubMed ID: 33435520
[TBL] [Abstract][Full Text] [Related]
33. Brazilian red propolis: phytochemical screening, antioxidant activity and effect against cancer cells.
de Mendonça IC; Porto IC; do Nascimento TG; de Souza NS; Oliveira JM; Arruda RE; Mousinho KC; dos Santos AF; Basílio-Júnior ID; Parolia A; Barreto FS
BMC Complement Altern Med; 2015 Oct; 15():357. PubMed ID: 26467757
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of herpes simplex virus type 1 by copper oxide nanoparticles.
Tavakoli A; Hashemzadeh MS
J Virol Methods; 2020 Jan; 275():113688. PubMed ID: 31271792
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of herpes simplex virus-1 infection by MBZM-N-IBT: in silico and in vitro studies.
Kumar A; De S; Moharana AK; Nayak TK; Saswat T; Datey A; Mamidi P; Mishra P; Subudhi BB; Chattopadhyay S
Virol J; 2021 May; 18(1):103. PubMed ID: 34039377
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of Spirogyra spp. algal extracts against herpes simplex virus type 1 and 2 infection.
Deethae A; Peerapornpisal Y; Pekkoh J; Sangthong P; Tragoolpua Y
J Appl Microbiol; 2018 Jun; 124(6):1441-1453. PubMed ID: 29532624
[TBL] [Abstract][Full Text] [Related]
37. Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread.
Cheshenko N; Herold BC
J Gen Virol; 2002 Sep; 83(Pt 9):2247-2255. PubMed ID: 12185280
[TBL] [Abstract][Full Text] [Related]
38. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model.
Uhlig N; Donner AK; Gege C; Lange F; Kleymann G; Grunwald T
Antiviral Res; 2021 Nov; 195():105190. PubMed ID: 34666109
[TBL] [Abstract][Full Text] [Related]
39. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1.
Arii J; Goto H; Suenaga T; Oyama M; Kozuka-Hata H; Imai T; Minowa A; Akashi H; Arase H; Kawaoka Y; Kawaguchi Y
Nature; 2010 Oct; 467(7317):859-62. PubMed ID: 20944748
[TBL] [Abstract][Full Text] [Related]
40. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22.
Wu N; Watkins SC; Schaffer PA; DeLuca NA
J Virol; 1996 Sep; 70(9):6358-69. PubMed ID: 8709264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
